EN DE
Watch Harte Hanks Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Harte Hanks Inc (HHS) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of Harte Hanks Inc stock $3.20, price $3.95, that is 19.0% below the price, quality 53 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials US

HH Harte Hanks Inc logo Thin data Nov 11, 2026

Harte Hanks Inc

HHS · US
Solid, but expensive

Our calculation puts a fair price 19% below what the stock costs today.

Low debt
Quality 53/100
Mixed Growth (revenue 5y −3.2 %/yr in USD)
Fair value $3.20 · Overvalued
Loss-making · -3.7% net margin (TTM)
Negative free cash flow
Trails peers (2/11)
Narrow moat 9/100 · thin data
Thin data
Estimate
Watch Harte Hanks Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$17.65 $2.00 Fair Value $3.20 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 11, 2026.

How to read this chart

60‑month range $2.00 – $17.65 · fair‑value band $2.40 – $4.00 · the $3.95 price screens above the $3.20 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 11, 2026.

Follow Harte Hanks in your weekly email

Every Wednesday you see whether Harte Hanks is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Harte Hanks, Inc. operates as a customer experience company in the United States and internationally. It operates through three segments: Revenue Solutions, Customer Care, and Fulfillment and Logistics.

Show moreShow less

It offers data and analytics, including audience identification, profiling, segmentation and prioritization, and predictive modeling and data strategy; research and intelligence, helps in understanding of customers, category, competitors, and capabilities; strategy, which plans and executes omnichannel marketing, demand generation, and customer experience programs; creative and content, including creative concepts, messaging and content assets for print, broadcast, direct mail, website, app, display, social, mobile, search engine marketing, and voice; marketing technology, a website and app development, e-commerce development and enablement, database building and management, platform architecture creation, and marketing automation; digital and multi-channel marketing execution and advertising; demand generation and account based marketing; and managed marketing services.

It also provides product, print-on-demand, and mail fulfillment services, including as printing on demand and distributing literature, managing product recalls, and promotional and branded product distribution; and third-party logistics and freight optimization services.

In addition, the company offers inside sales outsourcing, which provides B2B enterprises, and small to midsized businesses with an outsourced sales service; lead generation services; and sales play development, as well as customer service outsourcing, customer care technology and artificial intelligence transformation, and self-service technology.

It serves B2B, healthcare, pharmaceuticals, health insurance, consumer, travel, hospitality, streaming, entertainment, quick service restaurants, financial, fintech, automotive, and retail industries. The company was founded in 1923 and is headquartered in Chelmsford, Massachusetts.

Stock analysis

Harte Hanks Inc (HHS) currently trades at $3.95, while our estimate is $3.20, 19% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: $2.40 (bear) to $4.00 (bull), the price of $3.95 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 53/100 (solid quality), in the Industrials sector.

Mixed Growth: Spin-off in 2025: revenue and profit before it include the divested business. Growth is measured afresh from 2025.

Harte Hanks Inc reported revenue of $160M in FY2025 versus $195M in FY2021, a compound −4.8%/yr. Reported net income was −$811K in FY2025.

Key figures

Market cap $29.4M Micro · P/S ratio 0.19 · EPS (TTM) $−0.7800 · Net margin −3.7% · Return on equity −30.4% · Return on assets (EBIT) 5.3% (5-year average) · Operating margin −12.2% · Revenue (TTM) $155M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 9 out of 100 (low confidence).

What moves the price

The share trades about 15% below its 52-week high and 98% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Industrials peers we cover trades at 8% fair-value upside, at −19%, HHS screens richer than that median.

Fair Value

Bear $2.40 Fair Value $3.20 Bull $4.00
Price $3.95 · Downside -19.0%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 53/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 46
How much profit the company makes from its sales and capital
Quality Growth 32
Are margins and returns getting better?
Cashflow 40
Do the profits arrive as real cash?
Financial strength 59
Debt, balance sheet and risk of trouble
Investment 95
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 93
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 77
Distance to the 52-week high, does not count
New shares 76
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, no officer or director bought or sold shares on the open market.

Plus one other filing such as a grant, option exercise or tax withholding. It is not a market purchase or sale.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 10, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 55/100
Spin-off in 2025: revenue and profit before it include the divested business. Growth is measured afresh from 2025.
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.2%
Revenue growth 32 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.5%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−6.0% (2020) → 1.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

HHS screens overvalued: fair value 19% below the price. Compare with 3M Company →

Compare Harte Hanks Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Conglomerates · 349 stocks

Beats the industry median on 2/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 53 · Above median
Fair Value upside −19.0% · Below median
Profitability
Return on assets −0.9% · Bottom 25%
Net margin (12 months) −3.7% · Bottom 25%
Operating margin (12 months) −12.2% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −1.7% · Below median
Balance sheet
Debt / equity 0.24× · Above median

Valuation Multiplesvs Conglomerates median · lower = cheaper

P/B 1.43× · Pricier than median
P/S (12 months) 0.19× · Cheapest 25%
PEG 1.19× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)8 · sector 41
FUTURE (revenue growth)0 · sector 32
PAST (return on equity)0 · sector 24
HEALTH (low debt)88 · sector 90
DIVIDEND (yield)0 · sector 45

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Conglomerates stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
CITIC Limited 0267 HK$12.89 HK$25.74 +100% vs HHS
SK Inc 034730 480,000 KRW 632,391 KRW +32% vs HHS
CK Hutchison Holdings 0001 HK$71.95 HK$84.32 +17% vs HHS
Jardine Matheson Holdings J36 $61.61 $66.74 +8% vs HHS
Honeywell International Inc HON $228.22 $245.42 +8% vs HHS
SGH Limited SGH A$43.35 A$34.87 −20% vs HHS
Keppel Ltd BN4 9.76 SGD 3.87 SGD −60% vs HHS
3M Company MMM $189.37 $73.02 −61% vs HHS
Swire Pacific Limited 0019 HK$113.40 HK$27.75 −76% vs HHS
Doosan Corporation 000150 636,000 KRW 95,752 KRW −85% vs HHS

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Harte Hanks Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Harte Hanks Inc Fair Value". https://www.fairvalue-calculator.com/stock/HHS

Frequently asked questions

Is Harte Hanks Inc (HHS) overvalued or undervalued?
As of Nov 11, 2026, our estimate of fair value is $3.20 versus a price of $3.95, about 19% lower (overvalued).
What is the fair value of HHS?
Our estimate for Harte Hanks Inc is $3.20 (as of Nov 11, 2026), built from audited fundamentals. The current price: $3.95.
What is the quality score of HHS?
Harte Hanks Inc has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Harte Hanks Inc (HHS)?
Our calculated price target is the estimate of $3.20 (as of Nov 11, 2026). Cautious scenario $2.40, optimistic scenario $4.00. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Harte Hanks Inc stock forecast for 2026?
Our estimate puts fair value at $3.20, about 19% lower versus a price of $3.95 (overvalued). Cautious scenario $2.40, optimistic scenario $4.00. The calculation is refreshed regularly with new filings.
What is the revenue of Harte Hanks Inc (HHS)?
Harte Hanks Inc reported trailing-twelve-month revenue of about $155M (latest available figure, as of Nov 11, 2026).
What is the intrinsic value of Harte Hanks Inc (HHS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Harte Hanks Inc it is $3.20 per share (as of Nov 11, 2026), against a price of $3.95.
Is Harte Hanks Inc stock overvalued or undervalued in 2026?
As of Nov 11, 2026, HHS trades above its calculated fair value: price $3.95, fair value $3.20, a gap of about −19% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of HHS?
No. The price is what the market pays today ($3.95); the fair value is what the company's own numbers justify ($3.20). For Harte Hanks Inc the two are $0.7500 per share apart. That gap is exactly why we show both numbers side by side.
How much is Harte Hanks Inc worth?
The market values Harte Hanks Inc at about $29.4M (market capitalisation, as of Nov 11, 2026). Per share that is $3.95; our models calculate a fair value of $3.20 per share.
What do the bullish and bearish scenarios say about HHS?
Our models span a range for Harte Hanks Inc: cautious scenario $2.40, base $3.20, optimistic $4.00 per share (as of Nov 11, 2026, price $3.95). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of HHS?
The PEG ratio of Harte Hanks Inc is 1.19 (P/E divided by earnings growth, as of Nov 11, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Harte Hanks Inc (HHS)?
Balance-sheet figures for Harte Hanks Inc (as of Nov 11, 2026): return on equity −30.4%, debt of 0.24 per unit of equity. They feed the Quality Score of 53/100, which measures business quality independently of the share price.
How far is HHS from its 52-week high?
Harte Hanks Inc trades at $3.95, about 15% below its 52-week high of $4.65 and 98% above the low of $2.00 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of $3.20 is for.
Which stocks are comparable to Harte Hanks Inc?
From the same area (Industrials) we also value 3M Company, Honeywell International Inc, Swire Pacific Limited, CITIC Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Harte Hanks Inc stock attractive at the current price?
The data as of Nov 11, 2026: price $3.95, calculated fair value $3.20 (−19%), Quality Score 53/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Harte Hanks Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Harte Hanks Inc (HHS)?
The closing price on Nov 10, 2026 was $3.95. Our estimate is $3.20, about 19% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Harte Hanks Inc right now?
Solid but not exceptional quality (53/100) and above fair value, neither a clear bargain nor a standout compounder. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Harte Hanks Inc

How large is the market capitalisation of Harte Hanks Inc (HHS)?
The market capitalisation of Harte Hanks Inc is $29.4M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Harte Hanks Inc (HHS)?
The price-to-sales ratio of Harte Hanks Inc is 0.19 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Harte Hanks Inc (HHS)?
Earnings per share at Harte Hanks Inc are $−0.7800. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Harte Hanks Inc (HHS)?
The net margin of Harte Hanks Inc is −3.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Harte Hanks Inc (HHS)?
The return on equity (ROE) of Harte Hanks Inc is −30.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Harte Hanks Inc (HHS)?
On an EBIT basis the return on assets of Harte Hanks Inc is 5.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Harte Hanks Inc (HHS)?
The operating margin of Harte Hanks Inc is −12.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Harte Hanks Inc (HHS)?
Revenue at Harte Hanks Inc is growing −1.7% versus a year earlier (3y avg −8.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Harte Hanks Inc (HHS)?
Earnings per share at Harte Hanks Inc are growing −90.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Harte Hanks Inc (HHS) generate?
The free cash flow of Harte Hanks Inc is −$4.5M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Harte Hanks Inc (HHS) carry?
The net debt of Harte Hanks Inc is $16.8M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Harte Hanks Inc in the live analysis

One click puts Harte Hanks Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.